tiprankstipranks
Somnigroup International (SGI)
NYSE:SGI
Want to see SGI full AI Analyst Report?

Somnigroup International (SGI) AI Stock Analysis

674 Followers

Top Page

SGI

Somnigroup International

(NYSE:SGI)

Select Model
Select Model
Select Model
Neutral 67 (OpenAI - 5.2)
Rating:67Neutral
Price Target:
$78.00
â–²(9.00% Upside)
Action:Reiterated
Date:07/28/26
The score is driven primarily by stable-to-improving financial performance (strong cash generation and improving profitability, tempered by leverage/coverage considerations). Earnings-call guidance and synergy progress add support, while technicals are mixed-to-weak versus key moving averages and valuation appears relatively full with a modest dividend yield.
Positive Factors
Strong Cash Generation
Consistent, sizable operating and free cash flow provides durable internal funding for capex, dividends, buybacks and debt paydown. High FCF to net income (~0.78) indicates earnings translate into cash, supporting financial flexibility over the next 2–6 months and beyond.
Negative Factors
Elevated / Volatile Leverage
Although leverage has moderated, the company’s recent history of extreme leverage volatility and prior negative equity raises durability concerns. Elevated 3.1x net leverage limits financial flexibility, increases refinancing and covenant risk, and constrains shock absorption capacity.
Read all positive and negative factors
Positive Factors
Negative Factors
Strong Cash Generation
Consistent, sizable operating and free cash flow provides durable internal funding for capex, dividends, buybacks and debt paydown. High FCF to net income (~0.78) indicates earnings translate into cash, supporting financial flexibility over the next 2–6 months and beyond.
Read all positive factors

Somnigroup International (SGI) vs. SPDR S&P 500 ETF (SPY)

Somnigroup International Business Overview & Revenue Model

Company Description
Somnigroup International Inc., operating as Somni, leads the field in advanced sleep technology and holistic wellness solutions. They engineer groundbreaking products specifically designed to elevate sleep quality. Their approach seamlessly integr...
How the Company Makes Money
null...

Somnigroup International Earnings Call Summary

Earnings Call Date:May 07, 2026
(Q1-2026)
|
% Change Since: |
Next Earnings Date:Aug 06, 2026
Earnings Call Sentiment Positive
Overall the call communicated a predominantly positive operational and financial performance: strong revenue growth (+12%), robust margin expansion and cash generation, meaningful synergy realization, international outperformance, and a clear plan to offset commodity inflation via pricing. Notable near-term headwinds include weaker industry demand (mid-single-digit decline), Mattress Firm margin pressure, a Q2 commodity-related profit headwind (~$10 million) and elevated leverage (3.1x) that management expects to remediate. The strategic combination with Leggett & Platt and reaffirmed 2026 guidance (EPS $3.00–$3.40) further support a constructive outlook despite cyclical and timing risks.
Positive Updates
Revenue Growth
Net sales rose 12% year-over-year to $1.8 billion in Q1 2026, reflecting solid topline growth across segments.
Negative Updates
Industry Demand Weakness
Management believes global bedding demand declined mid-single digits in Q1 (worse than prior expectation of flat to slightly positive), reflecting macro/geopolitical headwinds and winter weather disruptions.
Read all updates
Q1-2026 Updates
Negative
Revenue Growth
Net sales rose 12% year-over-year to $1.8 billion in Q1 2026, reflecting solid topline growth across segments.
Read all positive updates
Company Guidance
Guidance for 2026 calls for adjusted EPS of $3.00–$3.40 on roughly $7.8 billion of consolidated sales (midpoint), with adjusted EBITDA targeted at about $1.45 billion; reported gross margin is expected to be slightly above 45% with nearly 100 basis points of net margin expansion from synergies and operating leverage. Management assumes the global bedding industry will be flat to slightly down, with Tempur Sealy North America like‑for‑like sales growing mid‑single digits, international like‑for‑like growth mid‑single digits, and Mattress Firm like‑for‑like sales growing low‑single digits; intercompany eliminations (between Mattress Firm and Tempur Sealy) are expected to represent ~23% of global Tempur Sealy sales. The plan anticipates the pricing actions will be dollar‑neutral for the year (a ~$50 million uplift to back‑half 2026 like‑for‑like sales and ~ $100 million annualized), a Q2 commodity timing headwind of about $10 million to Tempur Sealy profits, Q1 synergy run‑rate of $15 million (sales) and $50 million (cost), ~ $700 million of advertising, CapEx of ~ $225 million in 2026 (including ~$75 million for Mattress Firm refreshes) with normalized CapEx ~ $200 million thereafter, interest expense of about $230 million, a 25% tax rate, ~213 million diluted shares, and a commitment to deploy at least 50% of 2026 free cash flow to dividends and buybacks while returning leverage (Q1 at 3.1x) to the 2–3x adjusted EBITDA target.

Somnigroup International Financial Statement Overview

Summary
Income statement and cash flow trends are solid (strong TTM revenue growth, ~44% gross margin, improving net margin, and healthy TTM operating/free cash flow). Offsetting factors include margins still below earlier peaks and balance-sheet risk flags from prior leverage/equity volatility plus only modest operating cash flow coverage of debt.
Income Statement
74
Positive
Balance Sheet
63
Positive
Cash Flow
71
Positive
BreakdownTTMDec 2025Dec 2024Dec 2023Dec 2022Dec 2021
Income Statement
Total Revenue7.67B7.48B4.93B4.93B4.92B4.93B
Gross Profit3.40B3.32B2.18B2.13B2.05B2.16B
EBITDA1.21B1.04B804.20M739.30M807.30M1.00B
Net Income521.40M384.10M384.30M368.10M455.70M624.50M
Balance Sheet
Total Assets11.54B11.61B5.98B4.55B4.36B4.32B
Cash, Cash Equivalents and Short-Term Investments110.80M134.90M117.40M74.90M69.40M300.70M
Total Debt6.53B8.26B4.47B3.27B3.37B2.86B
Total Liabilities8.38B8.50B5.41B4.22B4.37B4.03B
Stockholders Equity3.15B3.11B559.00M323.40M-22.10M285.80M
Cash Flow
Free Cash Flow736.80M633.20M569.20M384.90M72.30M599.80M
Operating Cash Flow940.20M800.10M666.50M570.30M378.80M723.10M
Investing Cash Flow-226.10M-3.02B-96.70M-187.80M-315.60M-555.70M
Financing Cash Flow-729.90M616.90M1.08B-384.30M-279.10M76.50M

Somnigroup International Technical Analysis

Technical Analysis Sentiment
Negative
Last Price71.56
Price Trends
50DMA
72.05
Negative
100DMA
73.28
Negative
200DMA
81.04
Negative
Market Momentum
MACD
-0.85
Positive
RSI
46.86
Neutral
STOCH
26.08
Neutral
Evaluating momentum and price trends is crucial in stock analysis to make informed investment decisions. For SGI, the sentiment is Negative. The current price of 71.56 is below the 20-day moving average (MA) of 71.83, below the 50-day MA of 72.05, and below the 200-day MA of 81.04, indicating a bearish trend. The MACD of -0.85 indicates Positive momentum. The RSI at 46.86 is Neutral, neither overbought nor oversold. The STOCH value of 26.08 is Neutral, not indicating any strong overbought or oversold conditions. Overall, these indicators collectively point to a Negative sentiment for SGI.

Somnigroup International Risk Analysis

Somnigroup International disclosed 21 risk factors in its most recent earnings report. Somnigroup International reported the most risks in the "Finance & Corporate" category.
Finance & Corporate - Financial and accounting risks. Risks related to the execution of corporate activity and strategy
Latest Risks Added 0 New Risks

Somnigroup International Peers Comparison

Overall Rating
UnderperformOutperform
Sector (61)
Financial Indicators
Name
Overall Rating
Market Cap
P/E Ratio
ROE
Dividend Yield
Revenue Growth
EPS Growth
71
Outperform
$23.41B31.6717.78%1.23%2.69%46.04%
69
Neutral
$36.94B22.6415.18%4.30%-0.08%53.37%
67
Neutral
$13.74B26.2417.26%0.89%43.53%54.97%
61
Neutral
$18.38B12.79-2.54%3.03%1.52%-15.83%
61
Neutral
$36.28B17.16143.64%4.63%-16.17%-13.40%
60
Neutral
$73.06B35.89475.13%2.31%5.24%-29.04%
58
Neutral
$11.55B15.462826.17%5.19%-3.69%10.26%
* Consumer Cyclical Sector Average
Performance Comparison
Ticker
Company Name
Price
Change
% Change
SGI
Somnigroup International
65.33
-8.18
-11.13%
CHD
Church & Dwight
98.81
8.49
9.40%
CLX
Clorox
95.53
-23.30
-19.61%
CL
Colgate-Palmolive
91.30
9.97
12.26%
KMB
Kimberly Clark
109.31
-17.61
-13.88%
KVUE
Kenvue, Inc.
19.24
-1.96
-9.23%

Somnigroup International Corporate Events

Business Operations and StrategyPrivate Placements and FinancingRegulatory Filings and Compliance
Somnigroup International Refinances And Extends Credit Facilities
Positive
Jul 27, 2026
On July 27, 2026, Somnigroup International Inc. executed Amendment No. 5 to its 2023 Credit Agreement, refinancing and extending its senior secured facilities. The company secured a new $1.2 billion term loan A and expanded its revolving credit co...
Business Operations and StrategyM&A TransactionsRegulatory Filings and Compliance
Somnigroup Clears Key Antitrust Hurdle in Leggett Merger
Positive
Jun 4, 2026
On April 13, 2026, Somnigroup International Inc. agreed to merge its wholly owned subsidiary Sparrow Unity Corporation with Leggett Platt, Incorporated, leaving Leggett Platt as a direct wholly owned subsidiary of Somnigroup. On June 4, 2026, th...
Business Operations and StrategyExecutive/Board ChangesShareholder Meetings
Somnigroup Stockholders Approve Governance Changes and Share Increase
Positive
May 15, 2026
At Somnigroup International’s annual meeting of stockholders held on May 13, 2026, investors representing nearly all outstanding shares participated in key governance decisions, including the election of the full slate of board nominees and ...
Business Operations and StrategyStock BuybackDividendsM&A Transactions
Somnigroup Highlights Vertically Integrated Bedding Growth Strategy
Positive
May 7, 2026
On May 7, 2026, Somnigroup International Inc. released an updated investor presentation outlining its strategy as a vertically integrated bedding leader spanning design, manufacturing, logistics and omnichannel retail under brands such as Tempur-P...
Glossary
BuyA stock rated as a "Buy" is expected to perform better than the overall market or a specific benchmark over the near-to-medium term. This rating suggests the stock is likely to deliver higher returns compared to other stocks in the same sector or market index. Note: This is not investment advice; please consult a financial advisor before making investment decisions.
HoldA stock rated as a "Hold" is expected to perform in line with the overall market or a specific benchmark. This rating indicates that the stock is neither particularly compelling nor unfavorable for investment. Note: This is not investment advice; please consult a financial advisor before making investment decisions.
SellA stock rated as a "Sell" is expected to perform worse than the overall market or a specific benchmark over the near-to-medium term. This rating suggests the stock may deliver lower returns compared to other stocks in the same sector or market index. Note: This is not investment advice; please consult a financial advisor before making investment decisions.

Disclaimer

This AI Analyst Stock Report is automatically generated by our AI systems using advanced algorithms and publicly available financial, technical, and market data. While the information provided aims to be accurate and insightful, it is intended for informational purposes only and should not be considered financial advice. Any content created by an AI (Artificial Intelligence) system may contain inaccuracies and/or contain errors. Investing in stocks carries inherent risks, and past performance is not indicative of future results. This report does not account for your personal financial circumstances, objectives, or risk tolerance. Always conduct your own research or consult with a qualified financial advisor before making investment decisions. The analysis and recommendations provided are based on historical and current data and may not fully reflect future market conditions or unexpected developments. Neither the creators of this report nor its affiliated entities guarantee the accuracy, completeness, or reliability of the information presented. Use this report at your own discretion and risk.Date of analysis: Jul 28, 2026